Macomics secures investment to develop cancer therapies
New start up launches with a £3.2 million seed funding.
Macomics is leading academic research around macrophage biology, particularly in cancer.
Developed by Professor Jeffrey Pollard, Director of the MRC Centre for Reproductive Health at the University of Edinburgh, working with co-founder Dr Luca Cassetta.